Talvinen K - Search Results

1

Securin promotes the identification of favourable outcome in invasive breast cancer.

Talvinen K, Karra H, Hurme S, Nykänen M, Nieminen A, Anttinen J, Kuopio T, Kronqvist P. Talvinen K, et al. Br J Cancer. 2009 Sep 15;101(6):1005-10. doi: 10.1038/sj.bjc.6605237. Epub 2009 Aug 18. Br J Cancer. 2009. PMID: 19690544 Free PMC article.

2

Biochemical and clinical approaches in evaluating the prognosis of colon cancer.

Talvinen K, Tuikkala J, Grönroos J, Huhtinen H, Kronqvist P, Aittokallio T, Nevalainen O, Hiekkanen H, Nevalainen T, Sundström J. Talvinen K, et al. Anticancer Res. 2006 Nov-Dec;26(6C):4745-51. Anticancer Res. 2006. PMID: 17214335 Free article.

3

Proliferation marker securin identifies favourable outcome in invasive ductal breast cancer.

Talvinen K, Tuikkala J, Nevalainen O, Rantanen A, Hirsimäki P, Sundström J, Kronqvist P. Talvinen K, et al. Br J Cancer. 2008 Jul 22;99(2):335-40. doi: 10.1038/sj.bjc.6604475. Epub 2008 Jul 1. Br J Cancer. 2008. PMID: 18594525 Free PMC article.

4

Genomic changes of the 55 kDa subunit of DNA polymerase epsilon in human breast cancer.

Zhou Q, Effati R, Talvinen K, Pospiech H, Syväoja JE, Collan Y. Zhou Q, et al. Among authors: talvinen k. Cancer Genomics Proteomics. 2008 Sep-Oct;5(5):287-92. Cancer Genomics Proteomics. 2008. PMID: 19129559 Free article.

5

Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer.

Korkeila E, Talvinen K, Jaakkola PM, Minn H, Syrjänen K, Sundström J, Pyrhönen S. Korkeila E, et al. Among authors: talvinen k. Br J Cancer. 2009 Mar 24;100(6):874-80. doi: 10.1038/sj.bjc.6604949. Epub 2009 Feb 24. Br J Cancer. 2009. PMID: 19240720 Free PMC article.

6

Altered expression of p120catenin predicts poor outcome in invasive breast cancer.

Talvinen K, Tuikkala J, Nykänen M, Nieminen A, Anttinen J, Nevalainen OS, Hurme S, Kuopio T, Kronqvist P. Talvinen K, et al. J Cancer Res Clin Oncol. 2010 Sep;136(9):1377-87. doi: 10.1007/s00432-010-0789-8. Epub 2010 Feb 12. J Cancer Res Clin Oncol. 2010. PMID: 20151151

7

Securin predicts aneuploidy and survival in breast cancer.

Karra H, Pitkänen R, Nykänen M, Talvinen K, Kuopio T, Söderström M, Kronqvist P. Karra H, et al. Among authors: talvinen k. Histopathology. 2012 Mar;60(4):586-96. doi: 10.1111/j.1365-2559.2011.04107.x. Epub 2012 Jan 19. Histopathology. 2012. PMID: 22260438

8

Low cdc27 and high securin expression predict short survival for breast cancer patients.

Talvinen K, Karra H, Pitkänen R, Ahonen I, Nykänen M, Lintunen M, Söderström M, Kuopio T, Kronqvist P. Talvinen K, et al. APMIS. 2013 Oct;121(10):945-53. doi: 10.1111/apm.12110. Epub 2013 Jun 12. APMIS. 2013. PMID: 23755904

9

Prognostic implications of securin expression and sub-cellular localization in human breast cancer.

Gurvits N, Repo H, Löyttyniemi E, Nykänen M, Anttinen J, Kuopio T, Talvinen K, Kronqvist P. Gurvits N, et al. Among authors: talvinen k. Cell Oncol (Dordr). 2016 Aug;39(4):319-31. doi: 10.1007/s13402-016-0277-5. Epub 2016 Mar 16. Cell Oncol (Dordr). 2016. PMID: 26984614

10

Separase is a marker for prognosis and mitotic activity in breast cancer.

Gurvits N, Löyttyniemi E, Nykänen M, Kuopio T, Kronqvist P, Talvinen K. Gurvits N, et al. Among authors: talvinen k. Br J Cancer. 2017 Oct 24;117(9):1383-1391. doi: 10.1038/bjc.2017.301. Epub 2017 Aug 31. Br J Cancer. 2017. PMID: 28859055 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters